{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:32:02Z","timestamp":1773833522628,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010009","name":"Heilongjiang Provincial Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.prp.2020.153007","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T22:15:41Z","timestamp":1589580941000},"page":"153007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Tonsillar immunology in IgA nephropathy"],"prefix":"10.1016","volume":"216","author":[{"given":"Xinxin","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anchao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxue","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2020.153007_bib0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/IJNRD.S129227","article-title":"Primary IgA nephropathy: current challenges and future prospects","volume":"11","author":"Penfold","year":"2018","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"issue":"1","key":"10.1016\/j.prp.2020.153007_bib0010","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clim.2016.07.011","article-title":"IgA nephropathy enigma","volume":"172","author":"Mestecky","year":"2016","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.prp.2020.153007_bib0015","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.ekir.2017.07.002","article-title":"Inhibition of STAT3 signaling reduces IgA1 autoantigen production in IgA nephropathy","volume":"2","author":"Yamada","year":"2017","journal-title":"Kidney Int. Rep."},{"issue":"4","key":"10.1016\/j.prp.2020.153007_bib0020","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1523-1755.2004.00486.x","article-title":"Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy","volume":"65","author":"Xie","year":"2004","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.prp.2020.153007_bib0025","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrneph.2014.92","article-title":"Pathology of IgA nephropathy","volume":"10","author":"Roberts","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.prp.2020.153007_bib0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/0886022X.2019.1583113","article-title":"Hirudin ameliorates immunoglobulin A nephropathy by inhibition of fibrosis and inflammatory response","volume":"41","author":"Deng","year":"2019","journal-title":"Ren. Fail."},{"issue":"1","key":"10.1016\/j.prp.2020.153007_bib0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12882-016-0429-x","article-title":"Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case\u2013control study","volume":"18","author":"Shu","year":"2017","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.prp.2020.153007_bib0040","article-title":"Triptolide inhibits tonsillar IgA production by upregulating FDC-SP in IgA nephropathy","author":"Li","year":"2019","journal-title":"Histol. Histopathol."},{"issue":"7","key":"10.1016\/j.prp.2020.153007_bib0045","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s11255-018-1792-2","article-title":"Tonsillitis exacerbates renal injury in IgA nephropathy through promoting Th22 cells chemotaxis","volume":"50","author":"Gan","year":"2018","journal-title":"Int. Urol. Nephrol."},{"issue":"1","key":"10.1016\/j.prp.2020.153007_bib0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40620-014-0086-8","article-title":"Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy","volume":"28","author":"Vergano","year":"2015","journal-title":"J. Nephrol."},{"issue":"1","key":"10.1016\/j.prp.2020.153007_bib0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10157-018-1582-2","article-title":"Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis","volume":"23","author":"Suzuki","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"issue":"3","key":"10.1016\/j.prp.2020.153007_bib0060","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10157-018-1642-7","article-title":"Association between renal outcome and the number of steroid pulse therapies after tonsillectomy in patients with IgA nephropathy","volume":"23","author":"Daisuke","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"issue":"5","key":"10.1016\/j.prp.2020.153007_bib0065","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.transproceed.2017.03.063","article-title":"Long-term clinical outcomes of fimt and second kidney transplantation in patients with biopsy-pmven IgA nephropathy","volume":"49","author":"Kim","year":"2017","journal-title":"Transplant. Proc."},{"issue":"2","key":"10.1016\/j.prp.2020.153007_bib0070","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.kint.2017.03.015","article-title":"Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes","volume":"92","author":"Allen","year":"2017","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.prp.2020.153007_bib0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12882-018-0858-9","article-title":"Successful treatment of recurrent immunoglobulin a nephropathy using steroid pulse therapy plus tonsillectomy 10 years after kidney transplantation: a case presentation","volume":"19","author":"Katsumata","year":"2018","journal-title":"BMC Nephrol."},{"issue":"6","key":"10.1016\/j.prp.2020.153007_bib0080","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.anl.2018.04.009","article-title":"Steroid pulse therapy transiently destroys the discriminative histological structure of tonsils in IgA nephropathy: tonsillectomy should be performed before or just after steroid pulse therapy","volume":"45","author":"Adachi","year":"2018","journal-title":"Auris Nasus Larynx"},{"issue":"18","key":"10.1016\/j.prp.2020.153007_bib0085","volume":"8146","author":"Kondo","year":"2019","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.prp.2020.153007_bib0090","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/sj.ki.5002185","article-title":"Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels","volume":"71","author":"Moldoveanu","year":"2007","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.prp.2020.153007_bib0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000499110","article-title":"Loss of the golgi matrix protein 130 cause aberrant IgA1 glycosylation in IgA nephropathy","volume":"49","author":"Wang","year":"2019","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.prp.2020.153007_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002765","article-title":"Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis","volume":"8","author":"Kiryluk","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.prp.2020.153007_bib0105","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1172\/JCI74475","article-title":"The genetics and immunobiology of IgA nephropathy","volume":"124","author":"Kiryluk","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2020.153007_bib0110","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1074\/jbc.M113.512277","article-title":"Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes","volume":"289","author":"Suzuki","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2020.153007_bib0115","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1681\/ASN.2016060670","article-title":"Prognostic value of serum biomarkers of autoimmunity for recurrence of IgA nephropathy after kidney transplantation","volume":"28","author":"Berthoux","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.prp.2020.153007_bib0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/IJNRD.S129227","article-title":"Primary IgA nephropathy: current challenges and future prospects","volume":"11","author":"Penfold","year":"2018","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"10.1016\/j.prp.2020.153007_bib0125","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.prp.2020.153007_bib0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrneph.2015.208","article-title":"The mucosa-kidney axis in IgA nephropathy","volume":"12","author":"Floege","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.prp.2020.153007_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081636","article-title":"Periodontal disease bacteria specific to tonsil in IgA nephropathy patients predicts the remission by the treatment","volume":"9","author":"Nagasawa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2020.153007_bib0140","first-page":"2072","article-title":"Comprehensive microbiome analysis of tonsillar crypts in IgA nephropathy","author":"Watanabe","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.prp.2020.153007_bib0145","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s10157-014-1072-0","article-title":"Distribution of Streptococcus mutans strains with collagen-binding proteins in the oral cavity of IgA nephropathy patients","volume":"19","author":"Misaki","year":"2015","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.prp.2020.153007_bib0150","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1159\/000495061","article-title":"Impact of GADD34 on apoptosis of tonsillar mononuclear cells from IgA nephropathy patients by regulating Eif2\u03b1 phosphorylation","volume":"50","author":"Peng","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.prp.2020.153007_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2019.103925","article-title":"A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy","author":"Takahara","year":"2019","journal-title":"Cell. Immunol."},{"issue":"12","key":"10.1016\/j.prp.2020.153007_bib0160","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/00016489.2018.1522450","article-title":"The role of phosphorylcholine-specific immune responses in the tonsils and peripheral blood on IgA nephropathy","volume":"138","author":"Ohori","year":"2018","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.prp.2020.153007_bib0165","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.humimm.2017.02.004","article-title":"Up-regulation of CX3CR1 on tonsillar CD8-positive cells in patients with IgA nephropathy","volume":"78","author":"Otaka","year":"2017","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.prp.2020.153007_bib0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00011-012-0549-0","article-title":"Effect of tonsillar mononuclear cell supernatants in patients with IgA nephropathy on renal tubular epithelial cells","volume":"62","author":"Tang","year":"2013","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.prp.2020.153007_bib0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000440819","article-title":"Synthetic double-stranded RNA poly(I:C) aggravates IgA nephropathy by triggering IgA class switching recombination through the TLR3-BAFF Axis","volume":"42","author":"He","year":"2015","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.prp.2020.153007_bib0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biopha.2018.02.022","article-title":"MiR-133a\/133b inhibits Treg differentiation in IgA nephropathy through targeting FOXP3","volume":"101","author":"Jin","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2020.153007_bib0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/0886022X.2015.1128251","article-title":"The efficacy of tonsillectomy on clinical remission and relapse in patients with IgA nephropathy: a randomized controlled trial","volume":"38","author":"Yang","year":"2016","journal-title":"Ren. Fail."},{"issue":"4","key":"10.1016\/j.prp.2020.153007_bib0190","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s10157-015-1194-z","article-title":"Renal outcome after tonsillectomy plus corticosteroid pulse therapy in patients with immunoglobulin A nephropathy: results of a multicenter cohort study","volume":"20","author":"Hoshino","year":"2016","journal-title":"Clin. Exp. Nephrol."},{"issue":"4","key":"10.1016\/j.prp.2020.153007_bib0195","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00405-016-3904-x","article-title":"Clinical practice guideline: tonsillitis II. Surgical management","volume":"273","author":"Windfuhr","year":"2016","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.prp.2020.153007_bib0200","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2249.2001.01431.x","article-title":"Increase in tonsillar germinal centre B-1 cell numbers in IgA nephropathy (IgAN) patients and reduced susceptibility to Fas-mediated apoptosis","volume":"123","author":"Kodama","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.prp.2020.153007_bib0205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/0886022X.2015.1096730","article-title":"Efficacy of triptolide on the apoptosis of tonsillar mononuclear cells from patients with IgA nephropathy","volume":"38","author":"Yan","year":"2016","journal-title":"Ren. Fail."},{"key":"10.1016\/j.prp.2020.153007_bib0210","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/pcmr.12158","article-title":"Loss of Oca2 disrupts the unfolded protein response and increases resistance to endoplasmic reticulum stress in melanocytes","volume":"26","author":"Cheng","year":"2013","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.prp.2020.153007_bib0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135570","article-title":"Guanabenz treatment accelerates disease in a mutant SOD1 mouse model of ALS","volume":"10","author":"Vieira","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2020.153007_bib0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.1201396","article-title":"Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis","volume":"332","author":"Tsaytler","year":"2011","journal-title":"Science"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820305963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820305963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:42:04Z","timestamp":1759732924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033820305963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0344033820305963"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2020.153007","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tonsillar immunology in IgA nephropathy","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2020.153007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153007"}}